Full Archive
Everything We've Written
All of it — compound guides, protocol breakdowns, research notes. Use the tags to find what you're after.
4 articles publishedSémaglutide vs rétatrutide : préservation musculaire
Une méta-analyse récente compare la perte de masse musculaire sous sémaglutide et rétatrutide. Les résultats suggèrent une préservation comparable
Medicare GLP-1 Coverage: Are AOD-9604 and Semaglutide Now More Accessible?
Semaglutide gains narrow Medicare coverage for obesity with cardiovascular risk, while AOD-9604 remains excluded due to lack of approval and
Semaglutide and Menopause: Protecting Bone Density
Examining whether semaglutide-induced weight loss during menopause accelerates bone density decline, what the evidence shows, and how to interpret skeletal safety data.
AOD-9604 vs Semaglutide for Bone Health During Weight Loss
Semaglutide produces modest BMD reductions during weight loss in clinical trials, while AOD-9604 lacks any published human bone-health data, making direct skeletal safety comparison...